Carl W. Langren Insider Trading

General | Insider Transactions | Monthly Overview

Address: C/O NEWLINK GENETICS CORPORATION 2503 SOUTH LOOP DR., SUITE 5100 AMES 50010 IA

Companies in which Carl W. Langren is an Insider

LUMOS PHARMA, INC.

Trading Symbol: NLNK
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Carl W. Langren: Chief Financial Officer, Principal Accounting Officer
Holdings: 11,494 shares
Current Value: $157,123
Latest Transaction: Apr 05 2021
$NLNK Market Capitalization: $408.17M
$NLNK Previous Close: $13.67

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Carl W. Langren

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 05 2021	NLNK	LUMOS PHARMA, INC.	Langren Carl W.	Chief Financial Off ...	Payment of Exercise	F	12.25	683	8,367	11,494	12.2 K to 11.5 K (-5.61 %)
Apr 03 2020	NLNK	LUMOS PHARMA, INC.	Langren Carl W.	Chief Financial Off ...	Option Exercise	A	7.87	45,000	354,150	45,000
Apr 03 2020	NLNK	LUMOS PHARMA, INC.	Langren Carl W.	Chief Financial Off ...	Grant	A	0.00	9,000	0	11,238	2.2 K to 11.2 K (+402.14 %)
Jan 06 2020	NLNK	NEWLINK GENETICS C ...	Langren Carl W.	Chief Financial Off ...	Payment of Exercise	F	2.21	281	621	20,144	20.4 K to 20.1 K (-1.38 %)
Aug 02 2019	NLNK	NEWLINK GENETICS C ...	Langren Carl W.	Chief Financial Off ...	Option Exercise	A	1.77	14,293	25,299	14,293
Aug 02 2019	NLNK	NEWLINK GENETICS C ...	Langren Carl W.	Chief Financial Off ...	Option Exercise	A	1.77	24,250	42,923	24,250
Aug 02 2019	NLNK	NEWLINK GENETICS C ...	Langren Carl W.	Chief Financial Off ...	Option Exercise	A	1.77	11,458	20,281	11,458

View all Carl W. Langren insider transactions.